About the Sector

Ogier Leman’s team have a track record in acting for Irish and UK financial institutions, alternative finance providers, insolvency practitioners, developers and investors on an asset, portfolio and project financing.

The life sciences industry in Ireland has grown remarkably over the last 20 years and has evolved from the ’90s to a new position of global significance.

The growth has seen Ireland become a natural hub for the MedTech & pharma giants in a similar fashion to the infiltration of the big US data Tech companies. Ireland is now a leading location for pharmaceutical and medical technology companies such as Abbot, Allergan, Boston Scientific, GSK, Lilly, Medtronic, MSD, Novartis, Pfizer and Stryker. Alongside this, an indigenous start-up culture has developed.

The uncertainty around Brexit has affected the Life Sciences & MedTech market particularly in relation to CE Marking and Marketing Authorisation Holders, these issues aside a real opportunity exists also for businesses in this area who wish to expand their presence in the EU-27 remaining member states post-Brexit.

As a major player, Ireland must anticipate these Brexit related changes along with the constant innovation and disruptive technologies in the sector. As Ireland’s tech law firm, Ogier Leman is ideally positioned to help Life Sciences business to capitalise on the opportunities.

Our Services

Corporate transactions;

  • Equity investment and funding;
  • Mergers and acquisitions;
  • Group restructurings and reorganisations;
  • Asset sales and acquisitions; and
  • Corporate governance advice.

Commercial contracts;

  • Sales, distribution, manufacturing, research and development; and
  • IP licensing agreements.

Data Protection & GDPR compliance (particularly relevant for medical technology sectors who are collecting personal data through medical or digital health software applications).

Our Experience

The Corporate team at Ogier Leman have significant experience in the provision of legal services to Irish companies and investors in the life sciences sector, including companies in the medical devices, diagnostics, pharmaceutical, biotechnology and medical technology sectors.

We advise companies in these sectors at all stages of their life cycle, ranging from start-ups to large multi-nationals.

Our Clients

A pharmaceutical company who develop and commercialize drugs to patients affected by gastrointestinal, dermatological and women’s health;

  • An Irish based implant manufacturer;
  • A fast-growing Irish startup in the area of mobile oral health technology;
  • A pharmaceutical group specialising in therapies for rare diseases;
  • A US-based investment manager specialising in healthcare and life sciences;
  • An institutional investor in respect of an investment into a leading medication adherence technology company; and
  • A leading provider of air purification technology to remove airborne pathogens.

Your Contact

Edon Byrnes

Partner, Corporate, Head of Life Sciences


TEL: +353 1 639 3000

Email: ireland@ogier.com